{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T10:46:47Z","timestamp":1793530007915,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007075","name":"European Society for Medical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.esmoop.2025.105767","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:24:16Z","timestamp":1761528256000},"page":"105767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Promoting equitable access to financial services to end financial discrimination against cancer survivors in Europe: scientific and ethical reasons"],"prefix":"10.1016","volume":"10","author":[{"given":"F.","family":"Andr\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Soldato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Vaz-Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Harbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"de Azambuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-Y.","family":"Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.esmoop.2025.105767_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105767_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.annonc.2021.12.007","article-title":"European cancer mortality predictions for the year 2022 with focus on ovarian cancer","volume":"33","author":"Dalmartello","year":"2022","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105767_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1470-2045(23)00646-0","article-title":"Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study","volume":"25","author":"De Angelis","year":"2024","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2025.105767_bib5","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/1055-9965.EPI-16-0133","article-title":"Anticipating the \u201cSilver Tsunami\u201d: prevalence trajectories and comorbidity burden among older cancer survivors in the United States","volume":"25","author":"Bluethmann","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.esmoop.2025.105767_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","article-title":"American Cancer Society\/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline","volume":"34","author":"Runowicz","year":"2016","journal-title":"J Clin Oncol"},{"issue":"27","key":"10.1016\/j.esmoop.2025.105767_bib8","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1200\/JCO.21.00277","article-title":"Dynamics of long-term patient-reported quality of life and health behaviors after adjuvant breast cancer chemotherapy","volume":"40","author":"Di Meglio","year":"2022","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.esmoop.2025.105767_bib9","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1200\/JCO.21.01958","article-title":"Long-term longitudinal patterns of patient-reported fatigue after breast cancer: a group-based trajectory analysis","volume":"40","author":"Vaz-Luis","year":"2022","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2025.105767_bib10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.annonc.2022.07.1941","article-title":"ESMO expert consensus statements on cancer survivorship: promoting high-quality survivorship care and research in Europe","volume":"33","author":"Vaz-Luis","year":"2022","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2025.105767_bib11","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2015.64.6620","article-title":"Financial insolvency as a risk factor for early mortality among patients with cancer","volume":"34","author":"Ramsey","year":"2016","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.esmoop.2025.105767_bib12","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/annonc\/mdw433","article-title":"The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy","volume":"27","author":"Perrone","year":"2016","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105767_bib13","first-page":"80","article-title":"Financial toxicity, part I: a new name for a growing problem","volume":"27","author":"Zafar","year":"2013","journal-title":"Oncol (Williston Park)"},{"issue":"4","key":"10.1016\/j.esmoop.2025.105767_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","article-title":"The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient\u2019s experience","volume":"18","author":"Zafar","year":"2013","journal-title":"Oncologist"},{"issue":"18","key":"10.1016\/j.esmoop.2025.105767_bib15","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1200\/JCO.2010.33.3179","article-title":"Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer","volume":"29","author":"Neugut","year":"2011","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.esmoop.2025.105767_bib16","doi-asserted-by":"crossref","first-page":"e755","DOI":"10.1200\/JOP.2016.011049","article-title":"Relationships among financial distress, emotional distress, and overall distress in insured patients with cancer","volume":"12","author":"Meeker","year":"2016","journal-title":"J Oncol Pract"},{"issue":"9","key":"10.1016\/j.esmoop.2025.105767_bib17","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1634\/theoncologist.2015-0026","article-title":"Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients","volume":"20","author":"Delgado-Guay","year":"2015","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105767_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JOP.2014.001542","article-title":"Population-based assessment of cancer survivors\u2019 financial burden and quality of life: a prospective cohort study","volume":"11","author":"Zafar","year":"2015","journal-title":"J Oncol Pract"},{"issue":"15","key":"10.1016\/j.esmoop.2025.105767_bib19","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.2015.63.2232","article-title":"Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer","volume":"34","author":"Lathan","year":"2016","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2025.105767_bib20","first-page":"4645","article-title":"Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review","volume":"28","author":"Longo","year":"2020","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105767_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw205","article-title":"Financial hardships experienced by cancer survivors: a systematic review","volume":"109","author":"Altice","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105767_bib22","first-page":"889","article-title":"The perceived cancer-related financial hardship among patients and their families: a systematic review","volume":"23","author":"Azzani","year":"2015","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.esmoop.2025.105767_bib23","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/pon.5021","article-title":"Returning to work after cancer: survivors\u2019, caregivers\u2019, and employers\u2019 perspectives","volume":"28","author":"Fitch","year":"2019","journal-title":"Psychooncology"},{"issue":"7","key":"10.1016\/j.esmoop.2025.105767_bib24","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1200\/JCO.19.01726","article-title":"Impact of breast cancer treatment on employment: results of a multicenter prospective cohort study (CANTO)","volume":"38","author":"Dumas","year":"2020","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2025.105767_bib25","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jhealeco.2013.08.004","article-title":"Effects of breast and colorectal cancer on labour market outcomes-average effects and educational gradients","volume":"32","author":"Heinesen","year":"2013","journal-title":"J Health Econ"},{"key":"10.1016\/j.esmoop.2025.105767_bib26","series-title":"The effects of breast cancer on individual labour market outcomes: an evaluation from an administrative panel in France","first-page":"103","author":"Barnay","year":"2019"},{"issue":"5","key":"10.1016\/j.esmoop.2025.105767_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.esmoop.2025.105767_bib28","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/annonc\/mdz140","article-title":"Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications","volume":"30","author":"Witte","year":"2019","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105767_bib29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.esmoop.2025.105767_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70779","article-title":"Cross-cultural validation of the COmprehensive Score for Financial Toxicity (COST) measure in an Australian sample","volume":"14","author":"Kim","year":"2025","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.esmoop.2025.105767_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102192","article-title":"Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients","volume":"8","author":"Arenare","year":"2023","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105767_bib32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12885-024-13230-5","article-title":"Financial toxicity questionnaire (FIT): development and validation of the Italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment","volume":"25","author":"Smussi","year":"2025","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.esmoop.2025.105767_bib33","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.6004\/jnccn.2019.7305","article-title":"Financial burdens of cancer treatment: a systematic review of risk factors and outcomes","volume":"17","author":"Smith","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"10.1016\/j.esmoop.2025.105767_bib34","first-page":"7159","article-title":"Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis","volume":"30","author":"Donkor","year":"2022","journal-title":"Support Care Cancer"},{"issue":"18","key":"10.1016\/j.esmoop.2025.105767_bib35","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1002\/cncr.35367","article-title":"Interventions to mitigate cancer-related medical financial hardship: a systematic review and meta-analysis","volume":"130","author":"Rashidi","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.esmoop.2025.105767_bib37","series-title":"Access to Financial Products for Persons with a History of Cancer in EU Member States: an Exploratory Study","year":"2022"},{"key":"10.1016\/j.esmoop.2025.105767_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejca.2021.12.001","article-title":"Towards an EU legislation on the right to be forgotten to access to financial services for cancer survivors","volume":"162","author":"Scocca","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.esmoop.2025.105767_bib36","series-title":"Unraveling the Mystery of Health: how People Manage Stress and Stay Well","first-page":"218","author":"Antonovsky","year":"1987"},{"key":"10.1016\/j.esmoop.2025.105767_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcpo.2020.100246","article-title":"A right to be forgotten for cancer survivors: a legal development expected to reflect the medical progress in the fight against cancer","volume":"25","author":"Scocca","year":"2020","journal-title":"J Cancer Policy"},{"key":"10.1016\/j.esmoop.2025.105767_bib42","author":"Munich"},{"issue":"11","key":"10.1016\/j.esmoop.2025.105767_bib43","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/annonc\/mdu383","article-title":"Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types","volume":"25","author":"Dal Maso","year":"2014","journal-title":"Ann Oncol"},{"issue":"15","key":"10.1016\/j.esmoop.2025.105767_bib44","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1200\/JCO.2009.25.9697","article-title":"Clinical relevance of conditional survival of cancer patients in Europe: age-specific analyses of 13 cancers","volume":"28","author":"Janssen-Heijnen","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2025.105767_bib45","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/(SICI)1097-0258(19990228)18:4<441::AID-SIM23>3.0.CO;2-M","article-title":"Mixture models for cancer survival analysis: application to population-based data with covariates","volume":"18","author":"De Angelis","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.esmoop.2025.105767_bib46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2288-11-96","article-title":"Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models","volume":"11","author":"Andersson","year":"2011","journal-title":"BMC Med Res Methodol"},{"issue":"10125","key":"10.1016\/j.esmoop.2025.105767_bib47","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.esmoop.2025.105767_bib48","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/ije\/dyaa128","article-title":"Cancer cure for 32 cancer types: results from the EUROCARE-5 study","volume":"49","author":"Dal Maso","year":"2020","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105767_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5\u2014a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.esmoop.2025.105767_bib50","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1002\/cam4.2276","article-title":"Prognosis and cure of long-term cancer survivors: a population-based estimation","volume":"8","author":"Dal Maso","year":"2019","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.esmoop.2025.105767_bib51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0300891619837896","article-title":"Excess risk of dying of other causes of cured cancer patients","volume":"105","author":"Botta","year":"2019","journal-title":"Tumori"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105767_bib52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/0962280218823234","article-title":"CENSUR working survival group. More accurate cancer-related excess mortality through correcting background mortality for extra variables","volume":"29","author":"Touraine","year":"2020","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105767_bib53","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12874-023-01876-x","article-title":"A new cure model that corrects for increased risk of non-cancer death: analysis of reliability and robustness, and application to real-life data","volume":"23","author":"Botta","year":"2023","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"10.1016\/j.esmoop.2025.105767_bib54","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41573-023-00723-4","article-title":"Trends in the approval of cancer therapies by the FDA in the twenty-first century","volume":"22","author":"Scott","year":"2023","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.esmoop.2025.105767_bib55","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S1470-2045(22)00637-4","article-title":"Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study","volume":"23","author":"Botta","year":"2022","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1016\/j.esmoop.2025.105767_bib56","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.esmoop.2025.105767_bib57","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1200\/JCO.23.01994","volume":"42","author":"Rastogi","year":"2024","journal-title":"J Clin Oncol"},{"issue":"suppl 9","key":"10.1016\/j.esmoop.2025.105767_bib58","first-page":"GS03","article-title":"Phase III study of adjuvant ado-trastuzumab emtansine vs trastuzumab for residual invasive HER2-positive early breast cancer after neoadjuvant chemotherapy and HER2-targeted therapy","volume":"84","author":"Loibl","year":"2024","journal-title":"Cancer Res"},{"issue":"46","key":"10.1016\/j.esmoop.2025.105767_bib59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/jncimonographs\/lgt004","article-title":"Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization","volume":"2013","author":"Gatta","year":"2013","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"9","key":"10.1016\/j.esmoop.2025.105767_bib60","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.33859","article-title":"A dynamic clinical calculator for estimating conditional recurrence-free survival after total neoadjuvant therapy for rectal cancer and either surgery or watch-and-wait management","volume":"5","author":"Weiser","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105767_bib61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41523-023-00530-5","article-title":"Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence","volume":"9","author":"Howard","year":"2023","journal-title":"NPJ Breast Cancer"},{"issue":"6","key":"10.1016\/j.esmoop.2025.105767_bib62","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.3390\/ijms26062486","article-title":"Circulating tumor DNA as a real-time biomarker for minimal residual disease and recurrence prediction in stage II colorectal cancer: a systematic review and meta-analysis","volume":"26","author":"Negro","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.esmoop.2025.105767_bib63","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jamaoncol.2024.3666","article-title":"Molecular, socioeconomic, and clinical factors affecting racial and ethnic disparities in colorectal cancer survival","volume":"10","author":"Yousef","year":"2024","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2025.105767_bib64","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000041370","article-title":"Building a cancer risk and survival prediction model based on social determinants of health combined with machine learning: a NHANES 1999 to 2018 retrospective cohort study","volume":"104","author":"Zhang","year":"2025","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105767_bib65","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41467-024-44946-4","article-title":"Robustly federated learning model for identifying high-risk patients with postoperative gastric cancer recurrence","volume":"15","author":"Feng","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105767_bib66","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1038\/s41467-022-33407-5","article-title":"Federated learning enables big data for rare cancer boundary detection","volume":"13","author":"Pati","year":"2022","journal-title":"Nat Commun"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925016369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925016369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T20:54:30Z","timestamp":1773003270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702925016369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2059702925016369"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.105767","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promoting equitable access to financial services to end financial discrimination against cancer survivors in Europe: scientific and ethical reasons","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.105767","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"105767"}}